Physiologic and pathologic changes of platelets in pregnancy

Platelets

Volumn 21, Issue 8, 2010, Pages 587-595

  Valera, Marie Cecile ^a,b,c   Parant, Olivier ^d   Vayssiere, Christophe ^d   Arnal, Jean François ^a   Payrastre, Bernard ^b,d  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

heritable platelet disorders; Platelets; preeclampsia; pregnancy; thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; CD40 LIGAND; CD63 ANTIGEN; DESMOPRESSIN; METHYLERGOMETRINE; OXYTOCIN; PADGEM PROTEIN; PREDNISOLONE; PROSTAGLANDIN; THROMBIN; TRANEXAMIC ACID;

BERNARD SOULIER DISEASE; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE CONCENTRATE; ESSENTIAL HYPERTENSION; GESTATIONAL THROMBOCYTOPENIA; GLANZMANN DISEASE; HELLP SYNDROME; HEMOSTASIS; HIGH RISK PATIENT; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LOW DRUG DOSE; MATERNAL HYPERTENSION; PATHOGENESIS; PERINATAL MORTALITY; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

BERNARD-SOULIER SYNDROME; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; FEMALE; HUMANS; HYPERTENSION; PLATELET COUNT; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOCYTOPENIA;

EID: 78149445346     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.509828     Document Type: Review

References (114)

1. McCrae KR. Thrombocytopenia in pregnancy: Differential diagnosis, pathogenesis, and management. Blood Rev 2003;17:7-14. (Pubitemid 36176207)
2. Levy JA, Murphy LD. Thrombocytopenia in pregnancy. The Journal of the American Board of Family Practice/American Board ofFamily Practice 2002;15:290-297.
3. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799.
4. Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy: A reappraisal of the threshold. Obstet Gynecol 2000;95:29-33. (Pubitemid 30001624)
5. Burrows RF, Kelton JG. Thrombocytopenia at delivery: A prospective survey of6715 deliveries. Am J Obstet Gynecol 1990;162:731-734.
6. Kam PC, Thompson SA, Liew AC Thrombocytopenia in the parturient. Anaesthesia 2004;59:255-264.
7. Cohen DL, Baglin TP. Assessment and management of immune thrombocytopenia in pregnancy and in neonates. Arch Dis Child 1995;72:F71-76.
8. Lescale KB, Eddleman KA, Cines DB, Samuels P, Lesser ML, McFarland JG, Bussel JB. Antiplatelet antibody testing in thrombocytopenic pregnant women. Am J Obstet Gynecol 1996;174:1014-1018. (Pubitemid 26111685)
9. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: Assessing the risks for the infant at delivery. Obstet Gynecol Surv 1993;48:781-788.
10. McCrae KR, Samuels P, SchreiberAD. Pregnancy-associated thrombocytopenia: Pathogenesis and management. Blood 1992;80:2697-2714.
11. Gill KK, Kelton JG. Management of idiopathic thrombocy-topenic purpura in pregnancy. Sem Hematol 2000; 37:275-289. (Pubitemid 30612906)
12. Ajzenberg N, Dreyfus M, Kaplan C, Yvart J, Weill B, Tchernia G. Pregnancy-associated thrombocytopenia revis-ited: Assessment and follow-up of 50 cases. Blood 1998;92:4573-4580. (Pubitemid 29005859)
13. Christiaens GC, Nieuwenhuis HK, Bussel JB. Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 1997;90:546-552.
14. Peracoli MT, Menegon FT, Borges VT, de Araujo Costa RA, Thomazini-Santos IA, Peracoli JC. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with pre-eclampsia. J Reproduct Immunol 2008;79:79-84.
15. Neiger R, Contag SA, Coustan DR. Preeclampsia effect on platelet count. Am J Perinatol 1992;9:378-380.
16. Jaremo P, Lindahl TL, Lennmarken C, Forsgren H. The use of platelet density and volume measurements to estimate the severity of pre-eclampsia. Eur J Clin Invest 2000;30:1113-1118. (Pubitemid 32064061)
17. Leduc L, Wheeler JM, Kirshon B, Mitchell P, Cotton DB. Coagulation profile in severe preeclampsia. Obstet Gynecol 1992;79:14-18.
18. Sharma SK, Philip J, Whitten CW, Padakandla UB, Landers DF. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology 1999;90:385-390. (Pubitemid 29071503)
19. Sibai BM, Spinnato JA, Watson DL, Hill GA, Anderson GD. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol 1984;64:319-325.
20. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002;287:3183-3186. (Pubitemid 34686089)
21. Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Brit J Obstet Gynaec 1995;102:111-117.
22. Dundar O, Yoruk P, Tutuncu L, Erikci AA, Muhcu M, Ergur AR, Atay V, Mungen E. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia. Prenatal Diag 2008; 28:1052-1056. (Pubitemid 352789473)
23. Morrison R, Crawford J, MacPherson M, Heptinstall S. Platelet behaviour in normal pregnancy, pregnancy compli-cated by essential hypertension and pregnancy-induced hypertension. Thromb Haemostasis 1985;54:607-611. (Pubitemid 16195301)
24. Louden KA, Broughton Pipkin F, Heptinstall S, Fox SC, Mitchell JR, Symonds EM. A longitudinal study of platelet behaviour and thromboxane production in whole blood in normal pregnancy and the puerperium. Brit J Obstet Gynaec 1990;97:1108-1114.
25. Sheu JR, Hsiao G, Shen MY, Lin WY, Tzeng CR. The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways. Clin Laboratory Haematol 2002;24:121-129. (Pubitemid 35013553)
26. Janes SL, Goodall AH. Flow cytometric detection of circu-lating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond) 1994;86:731-739.
27. Sheu JR, Hsiao G, Lin WY, Chen TF, Chien YY, Lin CH, Tzeng CR. Mechanisms involved in agonist-induced hyper-aggregability of platelets from normal pregnancy. J Biomed Sci 2002;9:17-25. (Pubitemid 34124203)
28. Horn EH, Cooper JA, Hardy E, Heptinstall S, Rubin PC Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. Clin Sci (Lond) 1995;89:91-99.
29. Horn EH, Cooper J, Hardy E, Heptinstall S, Rubin PC A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women. Clin Sci (Lond) 1991;80:549-558.
30. Bagamery K, Landau R, Kvell K, Graham J. Different platelet activation levels in non-pregnant, normotensive pregnant, pregnancy-induced hypertensive and pre-eclamptic women. A pilot study of flow cytometric analysis. Eur J Obstet Gyn R B 2005;121:117-118. (Pubitemid 40884649)
31. Kilby MD, Broughton Pipkin F, Symonds EM. Changes in platelet intracellular free calcium in normal pregnancy. Brit J Obstet Gynaec 1993;100:375-379. (Pubitemid 23121161)
32. Douglas JT, Shah M, Lowe GD, Belch JJ, Forbes CD, Prentice CR. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemostasis 1982;47:54-55. (Pubitemid 12180426)
33. Nicolini U, Guarneri D, Gianotti GA, Campagnoli C, Crosignani PG, Gatti L. Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol 1994; 83:65-69. (Pubitemid 24027383)
34. Gatti L, Tenconi PM, Guarneri D, Bertulessi C, Ossola MW, Bosco P, Gianotti GA. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: A longi-tudinal study. Int J Clin Lab Res 1994;24:217-219.
35. Star J, Rosene K, Ferland J, DiLeone G, Hogan J, Kestin A. Flow cytometric analysis of platelet activation throughout normal gestation. Obstet Gynecol 1997;90:562-568. (Pubitemid 27407397)
36. Harlow FH, Brown MA, Brighton TA, Smith SL, Trickett AE, Kwan YL, Davis GK. Platelet activation in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 2002;187:688-695.
37. Henn V, SlupskyJR, Grafe M, Anagnostopoulos I, Forster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction ofendothelial cells. Nature 1998;391:591-594. (Pubitemid 28157601)
38. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92:1041-1048. (Pubitemid 36588504)
39. Oron G, Ben-Haroush A, Hod M, Orvieto R, Bar J. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia. Obstet Gynecol 2006;107:896-900. (Pubitemid 43755591)
40. Erez O, Romero R, Hoppensteadt D, Fareed J, Chaiworapongsa T, Kusanovic JP, Mazaki-Tovi S, Gotsch F, Than NG, Vaisbuch E, et al. Premature labor: A state of platelet activation? J Perinat Med 2008;36:377-387.
41. Karalis I, Nadar SK, Al Yemeni E, Blann AD, Lip GY. Platelet activation in pregnancy-induced hypertension. Thromb Res 2005;116:377-383. (Pubitemid 41191189)
42. Rabini RA, Salvolini E, Staffolani R, Pugnaloni A, Simonelli L, Biagini G, Cester N, Garzetti GG, Mazzanti L. Biochemical-morphological modifications of platelet mem-branes during pregnancy-induced hypertension. Exp Mol Pathol 1995;63:175-185. (Pubitemid 27149446)
43. Kilby MD, Broughton Pipkin F, Symonds EM. Platelet cytosolic calcium in human pregnancy complicated by essen-tial hypertension. Am J Obstet Gynecol 1993;169:141-143. (Pubitemid 23223946)
44. Ahmed Y, Sullivan MH, Elder MG. Detection of platelet desensitization in pregnancy-induced hypertension is depen-dent on the agonist used. Thromb Haemostasis 1991;65:474-477.
45. Torres PJ, Escolar G, Palacio M, Gratacos E, Alonso PL, Ordinas A. Platelet sensitivity to prostaglandin E1 inhibition is reduced in pre-eclampsia but not in nonproteinuric gesta-tional hypertension. Brit J Obstet Gynaec 1996;103:19-24. (Pubitemid 26009920)
46. Walker JJ, Cameron AD, Bjornsson S, Singer CR, Fraser C. Can platelet volume predict progressive hypertensive disease in pregnancy? Am J Obstet Gynecol 1989;161:676-679. (Pubitemid 19252783)
47. Bosio PM, Cannon S, McKenna PJ, O'Herlihy C, Conroy R, Brady H. Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia. BJOG 2001;108:709-715. (Pubitemid 32778277)
48. Barr SM, Lees KR, Butters L, O'Donnell A, Rubin PC Platelet intracellular free calcium concentration in normoten-sive and hypertensive pregnancies in the human. Clin Sci (Lond) 1989;76:67-71. (Pubitemid 19039093)
49. Kilby MD, Broughton Pipkin F, Symonds EM. Calcium and platelets in normotensive and hypertensive human pregnancy. JHypertens 1992;10:997-1003.
50. Kobayashi T, Tokunaga N, Sugimura M, Suzuki K, Kanayama N, Nishiguchi T, Terao T. Coagulation/fibrinoly-sis disorder in patients with severe preeclampsia. Sem Thromb Hemostasis 1999;25:451-454. (Pubitemid 30010799)
51. Howarth S, Marshall LR, Barr AL, Evans S, Pontre M, Ryan N. Platelet indices during normal pregnancy and pre-eclampsia. Bri J Biomed Sci 1999;56:20-22. (Pubitemid 29160951)
52. Ahmed Y, van Iddekinge B, Paul C, Sullivan HF, Elder MG. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Brit J Obstet Gynaec 1993;100:216-220. (Pubitemid 23098343)
53. Piazze J, Gioia S, Maranghi L, Anceschi M. Mean platelet and red blood cell volume measurements to estimate the severity of hypertension in pregnancy. J Perinat Med 2006;34:246-247.
54. Ceyhan T, Beyan C, Baser I, Kaptan K, Gungor S, Ifran A. The effect of pre-eclampsia on complete blood count, platelet count and mean platelet volume. Annals Hematol 2006;85:320-322. (Pubitemid 43732655)
55. Makuyana D, Mahomed K, Shukusho FD, Majoko F. Liver and kidney function tests in normal and pre-eclamptic gestation-a comparison with non-gestational reference values. Cent Afr J Med 2002;48:55-59. (Pubitemid 44863881)
56. Briggs C. Quality counts: New parameters in blood cell counting. Int J Lab Hematol 2009;31:277-297.
57. Calvert SM, Tuffnell DJ, Haley J. Poor predictive value of platelet count, mean platelet volume and serum urate in hypertension in pregnancy. Eur J Obstet Gyn R B 1996;64:179-184. (Pubitemid 26068533)
58. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128:1173-1186. (Pubitemid 46427871)
59. Konijnenberg A, Stokkers EW, van der PostJA, Schaap MC, Boer K, Bleker OP, Sturk A. Extensive platelet activation in preeclampsia compared with normal pregnancy: Enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 1997;176:461-469. (Pubitemid 27107940)
60. Holthe MR, StaffAC, Berge LN, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and non-pregnant women. Am J Obstet Gynecol 2004;190:1128-1134. (Pubitemid 38561536)
61. Yoneyama Y, Suzuki S, Sawa R, Kiyokawa Y, Power GG, Araki T. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia. Obstet Gynecol 2001;97:366-370. (Pubitemid 32184694)
62. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-554.
63. Halim A, Kanayama N, el Maradny E, Nakashima A, Bhuiyan AB, Khatun S, Terao T. Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: Their significances. Am J Obstet Gynecol 1996;174:272-277. (Pubitemid 26037723)
64. Mellembakken JR, Solum NO, Ueland T, Videm V, Aukrust P. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia-possible role of platelet activation. Thromb Haemostasis 2001;86: 1272-1276. (Pubitemid 33064578)
65. Alacacioglu I, Ozcan MA, Piskin O, Yuksel F, Alacacioglu A, Demirkan F, Ozsan HG, Polat M, Ozgenc Y, Undar B. Increased concentration of soluble CD40 ligand in pre-eclampsia. Clin Appl Thromb Hemost 2007;13:201-205. (Pubitemid 46548376)
66. Norris LA, Gleeson N, Sheppard BL, Bonnar J. Whole blood platelet aggregation in moderate and severe pre-eclampsia. Brit J Obstet Gynaec 1993;100:684-688. (Pubitemid 23209768)
67. Takeuchi T, Yoneyama Y, Suzuki S, Sawa R, Otsubo Y, Araki T. Regulation of platelet aggregation in vitro by plasma adenosine in preeclampsia. Gynecol Obstet Invest 2001;51:36-39. (Pubitemid 32042144)
68. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecolog Scan 1995;74:772-776. (Pubitemid 26002174)
69. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WC. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study. BMJ 2003;326:845. (Pubitemid 36461414)
70. van Walraven C, Mamdani M, Cohn A, Katib Y, Walker M, Rodger MA. Risk of subsequent thromboembolism for patients with pre-eclampsia. BMJ 2003;326:791-792. (Pubitemid 36523584)
71. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: Systematic review. BMJ 2001;322:329-333. (Pubitemid 32150730)
72. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: A systematic review. Obstet Gynecol 2003;101:1319-1332. (Pubitemid 36694362)
73. Ruano R, Fontes RS, Zugaib M. Prevention of preeclampsia with low-dose aspirin-a systematic review and meta-analysis of the main randomized controlled trials. Clinics 2005;60:407-414.
74. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 2007; 369:1791-1798. (Pubitemid 46782996)
75. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane DB Syst Rev 2004;CD004659. (Pubitemid 46841297)
76. Gauer R, Atlas M, Hill J. Clinical inquiries. Does low-dose aspirin reduce preeclampsia and other maternal-fetal compli-cations? J Fam Practice 2008;57:54-56. (Pubitemid 351155815)
77. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. New Engl J Med 1998;338:701-705.
78. Rotchell YE, Cruickshank JK, Gay MP, Griffiths J, Stewart A, Farrell B, Ayers S, Hennis A, Grant A, Duley L, et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): A randomised trial for the prevention of pre-eclampsia and its complications. Brit J Obstet Gynaec 1998;105:286-292. (Pubitemid 28123577)
79. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343:619-629.
80. WinerN, Tsasaris V. [Latest developments: Management and treatment of preeclampsia]. J Gynecol Obst Bio R 2008;37(1):5-15.
81. Janes SL, Kyle PM, Redman C, Goodall AH. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thrombosis Haemostasis 1995;74:1059-1063.
82. Konijnenberg A, van der Post JA, Mol BW, Schaap MC, Lazarov R, Bleker OP, Boer K, Sturk A. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 1997;177:434-442. (Pubitemid 27385727)
83. de Vries JI, Vellenga E, Aarnoudse JG. Plasma beta-thromboglobulin in normal pregnancy and pregnancy-induced hypertension. Eur J Obstet Gyn R B 1983;14:209-216. (Pubitemid 13187384)
84. Zemel MB, Zemel PC, Berry S, Norman G, Kowalczyk C, Sokol RJ, Standley PR, Walsh MF, Sowers JR. Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. New Engl J Med 1990;323:434-438. (Pubitemid 20231554)
85. Haller H, Oeney T, Hauck U, Distler A, Philipp T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. Am J Hypertension 1989;2:238-243. (Pubitemid 19087202)
86. Kilby MD, Broughton Pipkin F, Cockbill S, Heptinstall S, Symonds EM. A cross-sectional study of basal platelet intracellular free calcium concentration in normotensive and hypertensive primigravid pregnancies. Clin Sci (Lond) 1990;78:75-80. (Pubitemid 20030054)
87. Kyle PM, Jackson MC, Buckley DC, de Swiet M, Redman CW. Platelet intracellular free calcium response to arginine vasopressin is similar in preeclampsia and normal pregnancy. Am J Obstet Gynecol 1995;172:654-660.
88. van der Post JA, Konijnenberg A, Boer K, Schaap MC, van Boxtel CE, Sturk A, Boer GJ, Swaab DF. Preeclampsia is not associated with altered platelet vasopressin binding and cytosolic Ca++ Xconcentration. Am J Obstet Gynecol 1993;169:1169-1178. (Pubitemid 24001634)
89. Ramasamy I. Inherited bleeding disorders: Disorders of platelet adhesion and aggregation. Crit Rev Oncol Hematology 2004;49:1-35. (Pubitemid 38088017)
90. Michalas S, Malamitsi-Puchner A, Tsevrenis H. Pregnancy and delivery in Bernard-Soulier syndrome. Acta Obstet Gynecol Scand 1984;63:185-186. (Pubitemid 14130525)
91. Heslop HE, Hickton CM, Laird E, Tait JD, Doig JR, Beard EJ. Twin pregnancy and parturition in a patient with the Bernard Soulier syndrome. Scan J Haematol 1986;37:71-73. (Pubitemid 16016206)
92. Peaceman AM, Katz AR, Laville M. Bernard-Soulier syn-drome complicating pregnancy: A case report. Obstet Gynecol 1989;73:457-459. (Pubitemid 19066066)
93. Saade G, Homsi R, Seoud M. Bernard-Soulier syndrome in pregnancy; a report of four pregnancies in one patient, and review of the literature. Eur J Obstet Gyn R B 1991;40:149-152.
94. Peng TC, Kickler TS, Bell WR, Haller E. Obstetric compli-cations in a patient with Bernard-Soulier syndrome. Am J Obstet Gynecol 1991;165:425-426.
95. Avila MA, Jacyntho C, Santos ML, Murta C, Hoirich S, Chalon I, Resende O. [Bernard-Soulier syndrome and pregnancy: A case report]. J Gynecol Obst Bio R 1992;21: 73-74.
96. Khalil A, Seoud M, Tannous R, Usta I, Shamseddine A. Bernard-Soulier syndrome in pregnancy: Case report and review of the literature. Clin Lab Haematol 1998;20:125-128. (Pubitemid 28206946)
97. Fujimori K, Ohto H, Honda S, Sato A. Antepartum diagnosis of fetal intracranial hemorrhage due to maternal Bernard-Soulier syndrome. Obstet Gynecol 1999; 94:817-819. (Pubitemid 29490892)
98. Kriplani A, Singh BM, Sowbernika R, Choudhry VP. Successful pregnancy outcome in Bernard-Soulier syn-drome. J Obstet Gynaecol Res 2005;31:52-56. (Pubitemid 40364148)
99. Kopec I, Maslanko K, Litmanowicz M, Stefanska E, Mikos A, Warzocha K. [Bernard-Soulier syndrome during preg-nancy: A case report]. Ginekol Pol 2005;76:824-827.
100. Rahimi G, Rellecke S, Mallmann P, Nawroth F. Course of pregnancy and birth in a patient with Bernard-Soulier syndrome-a case report. J Perinat Med 2005;33: 264-266. (Pubitemid 41069873)
101. Prabu P, Parapia LA. Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol 2006;28:198-201. (Pubitemid 43752219)
102. Sundqvist SB, Nilsson IM, Svanberg L, Cronberg S. Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia. Scand J Haematol 1981;27: 159-164. (Pubitemid 12229279)
103. Kashyap R, Kriplani A, Saxena R, Takkar D, Choudhry VP. Pregnancy in a patient of Glanzmann's thrombasthenia with antiplatelet antibodies. J Obstet Gynaec Res 1997;23: 247-250. (Pubitemid 27292478)
104. Capuzzo E, Polatti F, Zara C. Glanzmann's thrombasthenia and puerperium. Int J Gynaecol Obstet 1997;57:313-314. (Pubitemid 27252568)
105. Malhotra N, Chanana C, Deka D. Pregnancy in a patient of Glanzmann's thrombasthenia. Ind J Med Sci 2006;60: 111-113.
106. Vivier M, Treisser A, Naett M, Diemunsch P, Schmitt JP, Waller C, Tongio MM, Hemmendinger S, Lutz P. [Glanzmann's thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled cesarean section]. J Gynecol Obst Bio R 1989;18:507-513.
107. Poon MC, d'Oiron R, Hann I, Negrier C, de Lumley L, Thomas A, Karafoulidou A, Demers C, Street A, Huth-Kühne A, et al. Use ofrecombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Sem Hematol 2001;38:21-25. (Pubitemid 33130035)
108. Shamsi TS, Hossain N, Soomro N, Hasan JA, Noorani M, Kazi S, Quraishy MS, Jameel B, Sultan ST, Haider S. Use of recombinant factor VIIa for massive postpartum haem-horrage: Case series and review of literature. JPMA 2005;55:512-515.
109. Kale A, Bayhan G, Yalinkaya A, Yayla M. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery. J Perinat Med 2004;32: 456-458. (Pubitemid 39304419)
110. Bell JA, Savidge GF. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost 2003;9:167-170.
111. Leticee N, Kaplan C, Lemery D. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk? Eur J Obstet Gyn R B 2005;121:139-142. (Pubitemid 41074083)
112. Monrigal C, Beurrier P, Mercier FJ, Boyer-Neumann C, Gillard P. [Glanzmann's thrombasthenia and pregnancy: A case and review of the literature]. Ann Fr Anesth 2003;22:826-830. (Pubitemid 37465956)
113. Demers C, Derzko C, David M, Douglas J. Gynaecological and obstetric management of women with inherited bleeding disorders. Int J Gynaecol Obstet 2006;95:75-87.
114. Chi C, Lee CA, England A, Hingorani J, Paintsil J, Kadir RA. Obstetric analgesia and anaesthesia in women with inherited bleeding disorders. Thromb Haemostasis 2009;101:1104-1111.